Læknablaðið

Volume

Læknablaðið - 15.09.2003, Page 27

Læknablaðið - 15.09.2003, Page 27
FRÆÐIGREINAR / HRÖRNUNARSJÚKDÓMAR f HEILA Heimildir 1. Prusiner SB. Shattuck lecture - Neurodegenerative diseases and prions. N Engl J Med 2001; 344:1516-26. 2. Burns A, Byrne EJ, Maurer K. Alzheimer's disease. Lancet 2002; 360:163-5. 3. Bayer AJ. Molecular basis and genetic determinants of Alz- heimer's disease. Rev Clin Gerontol 1999; 9:297-304. 4. Prospero N, Tagle D. Normal and mutant huntingtin: Partners in crime? Nat Med 2000; 6:1208-9. 5. Cattaneo E, Rigamonti D, Zuccato C. The enigma of Hunting- ton's disease. Sci Am 2002; 287: 92-7. 6. Snædal J, Kristinsson J, Gunnarsdóttir S, Ólafsdóttir Á, Bald- vinsson M, Jóhannesson P. Copper, ceruloplasmin and super- oxide dismutase in patients with Alzheimer's disease. Dement Geriatr Cogn Disord 1998; 9: 239-42. 7. Sveinbjörnsdóttir S, Hicks AA, Jónsson Þ, Pétursson H, Guð- mundsson G, Frigge ML, et al. Familial aggregation of Park- inson’s disease in Iceland. N Engl J Med 2000; 343:1765-70. 8. Jóhannesson Þ. Alzheimer sjúkdómur: Meingerð og meðferð- armöguleikar. Heilbrigðismál 1998; (3): 27-9. 9. Jóhannesson Þ. Lyfjafræði miðtaugakerfisins. Menntamála- ráðuneytið/Háskóli Islands 1984. Kafli XI: 81-92. 10. Sigurðarson S. Epidemiology of scrapie in Iceland and ex- perience with control measures. In: Sub-acute spongiform encephalopathies. Proceedings seminar CEC agricultural re- search programme. Eds: Bradely R, Saver M, Marchant B. Kulwer Acad Publ 1991:233-42. 11. Jóhannesson Þ, Sigurðarson S. Sauðfjárriða - kopar, mangan og oxavarnarensím í íslensku sauðfé. Freyr 2002; 98: 56-9. 12. Taylor JP, Hardy J, Fischbeck KH. Toxic proteins in neuro- degenerative disease. Science 2002; 296:1991-5. 13. Miller RJ, Wilson SM. Neurological disease: UPS stops delivering! Trends Pharmacol Sci 2003; 24:18-23. 14. Yang LB, Lindholm K, Yan R, Citron M, Xia W, Yang XL, et al. Elevated p-secretase expression and enzymatic activity detec- ted in sporadic Alzheimer’s disease. Nature Med 2003; 9:3-4. 15. Hardy J, Selkoe DJ. The amyloid hypothesis of Alzheimer’s disease: Progress and problems on the road to therapeutics. Science 2002;297: 353-6. 16. McKeith IG, Perry EK, Perry RH. Report of the second de- mentia with Lewy body international workshop. Diagnosis and treatment. Neurology 1999; 53: 902-5. 17. Brown DR. Copper and prion disease. Brain Res Bull 2001; 55:165-73. 18. Bucciantini M, Giannoni E, Chiti F, Baroni F, Formigli L, Zurdo J, et al. Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases. Nature 2002;416:507-11. 19. Walsh DM, Klyubin I, Fadeeva JV, Cullen WK, Anwyl R. Wolfe MS, et al. Naturally secreted oligomers of amyloid p protein potently inhibit hippocampal long-term potentiation in vivo. Nature 2002; 416: 535-9. 20. Koppaka V, Axelsen PH. Accelerated accumulation of amyl- oid (J proteins on oxidatively damaged lipid membranes. Bio- chemistry 2000; 39:10011-6. 21. Borg DC. Oxygen free radicals and tissue injury. A reference outline. In: Oxygen free radicals in tissue damage. Eds. Tarr M, Sarason F. Birkháuser, Boston 1993: Kafli 2:12-53. 22. Markesbery WR, Carney JM. Oxidative alterations in Alz- heimer's disease. Brain Pathol 1999; 9:133-46. 23. Cuzzocrea S, Riley DP, Caputi AP, Salvemini D. Antioxidant therapy: A new pharmacoíogical approach in shock, inflam- mation, and ischemia/reperfusion injury. Pharmacol Rev 2001; 53:135-59. 24. Bush AI, Tanzi RE. The galvanization of p-amyloid in Alz- heimer's disease. Proc Natl Acad Sci 2002; 99: 7317-9. 25. Þórsdóttir G, Kristinsson J, Sveinbjörnsdóttir S, Snædal J, Jóhannesson Þ. Copper, ceruloplasmin, superoxide dismutase and iron parameters in Parkinson's disease. Pharmacol Toxi- col 1999; 85:239-43. 26. Þórsdóttir G, Kristinsson J, Hreiðarsson S, Snædal J, Jóhann- esson Þ. Copper, ceruloplasmin and superoxide dismutase (SOD) in patients with Down’s syndrome. Pharmacol Toxicol 2001; 89: 320-5. 27. Barber EF, Cousins RJ. Interleukin-1 - Stimulated induction of ceruloplasmin synthesis in normal and copper-deficient rats. JNutr 1988; 118: 375-81. 28. Marcus DL, Thomas C, Rodriguez C, Simberkoff K, Tsai JS, Strafaci JA, et al. Increased peroxidation and reduced antioxi- dant enzyme activity in Alzheimer's disease. Exper Neurol 1998; 150:40-4. 29. Nagy Z. Mechanism of neuronal death in Down's syndrome. J Neural Transm 1999; 57:233-45. 30. Przedborski S, Kostic V, Jackson-Lewis V, Naini AB, Simon- etti S, Fahn S, et al. Transgenic mice with increased Cu/Zn- superoxide dismutase activity are resistant to N-methyl-4- phenyl-l,2,3,6-tetrahydropyridine-induced neurotoxicity. J Neuroscience 1992; 12:1658-67. 31. Coyle JT, Puttfarcken P. Oxidative stress, glutamate and neurodegenerative disorders. Science 1993; 262: 689-95. 32. Hirsch EC, Hunot S. Nitric oxide, glial cells and neuronal degeneration in parkinsonism. Trends Pharmacol Sci 2000; 21: 163-5. 33. Rowland LP, Shneider NA. Amyotrophic lateral sclerosis. N Engl J Med 2001; 344:1688-1700. 34. Þórsdóttir G, Kristinsson J, Guðmundsson G, Snædal J, Jó- hannesson Þ. Copper, ceruloplasmin and superoxide dismu- tase in amyotrophic lateral sclerosis. Pharm Toxicol 2000; 87: 126-30. 35. Trottier G, Srivastave L, Walker C-D. Etiology of infantile autism: a review of recent advances in genetic and neurobio- logical research. J Psych Neuroscience 1999; 24:103-15. 36. Rodier PM. The early origins of autism. Sci Am 2000; 282: 38- 45. 37. Lauritsen MB, Mors O, Mortensen PB, Ewald H. Medical dis- orders among inpatients with autism in Denmark according to ICD-8: A nationwide register- based study. J Autism Deve- lopm Disord 2002; 32:115-9. 38. Wong B-S, Brown DR, Pan T, Whiteman M, Liu T, Xiadong B, et al. Oxidative impairment in scrapie-infected mice is associ- ated with brain metals perturbations and altered antioxidant activities. J Neurochem 2001; 79: 689-701. 39. Thackray AM, Knight R, Haswell SJ, Bujdoso R, Brown DR. Metal imbalance and compromised antioxidant function are early changes in prion disease. Biochem J 2002; 362:253-8. 40. Pattison IH, Jones KM. The astrocytic reaction in experi- mental scrapie in the rat. Res Vet Sci 1967; 8:160-5. 41. Aschner M, Vrana KE, Zheng W. Manganese uptake and distribution in the central nervous system. Neuro Toxicology 1999; 20:173-80. 42. Hensley K, Hall N, Subramaniam R, Cole P, Harris M, Akse- nov M, et al. Brain regional correspondence between Alz- heimer’s disease histopathology and biomarkers of protein oxidation. J Neurochem 1995; 65: 2146-56. 43. Burbeva GS, Aksenova MV, Makarenko IG. Decreased level of creatine kinase BB in the frontal cortex of Alzheimer patients. Dementia 1992; 3: 91-4. 44. Cherny RA, Atwood CS, Xilinas ME, Gray DN, Jones WD, McLean CA, et al. Treatment with a copper-zink chelator markedly and rapidly inhibits b-amyloid accumulation in Alzheimer s disease transgenic mice. Neuron 2001; 30: 665-76. 45. Sano M, Ernesto C, Thomas RG, Klauber MR, Schafer K, Grundman M, et al. A controlled trial of selegiline, alpha toco- pherol, or both as treatment for Alzheimer's disease. N Engl J Med 1997; 336:1216-22. 46. Palmer AM. Pharmacotherapy for Alzheimer's disease: pro- gress and prospects. Trends Pharmacol Sci 2002; 23:426-32. 47. Frankish H. Coenzyme Q10 could slow functional decline in Parkinson’s disease. Lancet 2002; 360:1227. 48. Iversen L. Small drugs lead the attack. Nature 2002; 417:231-3. 49. De Strooper B, Woodgett. Mental plaque removal. Nature 2003; 423:392-3. 50. Lawrence DM. Promising developments in Alzheimer’s im- munotherapy. Lancet 2002; 360:1227. 51. Haas C. New hope for Alzheimer's disease vaccine. Nature Med 2002; 8:1195-6. 52. Check E. Battle of the mind. Nature 2003; 422: 370-2. 53. Pasinetti GM, Pompl PM. Cyclo-oxygenase inhibitors and Alz- heimer’s: are we well ADAPTed? Lancet Neurol 2002; 1:403-4. 54. Launer L. Nonsteroidal anti-inflammatory drug use and the risk for Alzheimer’s disease. Drugs 2003; 63: 731-9. Læknablaðið 2003/89 671

x

Læknablaðið

Direct Links

If you want to link to this newspaper/magazine, please use these links:

Link to this newspaper/magazine: Læknablaðið
https://timarit.is/publication/986

Link to this issue:

Link to this page:

Link to this article:

Please do not link directly to images or PDFs on Timarit.is as such URLs may change without warning. Please use the URLs provided above for linking to the website.